Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

Autier P, 2000, OSTEOPOROSIS INT, V11, P373, DOI 10.1007-s001980070102; BLACK DM, 1993, OSTEOPOROSIS INT, V3, pS29; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359-jbmr.1999.14.5.821; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016-S0140-6736(96)07088-2; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007-s001980070075; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007-s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056-NEJM199212033272305; Colina RE, 1997, AM J GASTROENTEROL, V92, P704; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001; Cumming RG, 1997, J BONE MINER RES, V12, P1321, DOI 10.1359-jbmr.1997.12.9.1321; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001-jama.280.24.2077; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056-NEJM199610033351403; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241; Ettinger B., 1998, J MANAGE CARE PHARM, V4, P488; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001-jama.282.7.637; Ettinger MP, 2003, ARCH INTERN MED, V163, P2237, DOI 10.1001-archinte.163.18.2237; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Freedman KB, 2000, J BONE JOINT SURG AM, V82A, P1063; Gehlbach SH, 2000, OSTEOPOROSIS INT, V11, P577, DOI 10.1007-s001980070078; GENANT HK, 1993, J BONE MINER RES, V8, P1137; Gold DT, 1996, BONE, V18, pS185, DOI 10.1016-8756-3282(95)00500-5; Greendale GA, 2000, J AM GERIATR SOC, V48, P546; Gunnes M, 1998, ACTA ORTHOP SCAND, V69, P508, DOI 10.3109-17453679808997788; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001-jama.282.14.1344; Huang C, 1996, ARCH INTERN MED, V156, P2469, DOI 10.1001-archinte.156.21.2469; Ismail AA, 2001, OSTEOPOROSIS INT, V12, P85, DOI 10.1007-s001980170138; Ismail AA, 1998, OSTEOPOROSIS INT, V8, P291, DOI 10.1007-s001980050067; Ismail AA, 1999, OSTEOPOROSIS INT, V9, P206, DOI 10.1007-s001980050138; JACOBSEN SJ, 1992, EPIDEMIOLOGY, V3, P515, DOI 10.1097-00001648-199211000-00009; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001-archinte.159.11.1215; Kamel HK, 2002, DRUG AGING, V19, P1, DOI 10.2165-00002512-200219010-00001; Kamel HK, 2000, AM J MED, V109, P326, DOI 10.1016-S0002-9343(00)00457-5; KANIS JA, 1992, BONE, V13, pS1, DOI 10.1016-8756-3282(92)90189-4; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001-jama.285.3.320; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007-s001980050093; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056-NEJM200102013440503; MELTON LJ, 1988, J CLIN EPIDEMIOL, V41, P985; MELTON LJ, 1986, CURRENT CONCEPTS BON, P385; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007-BF01623271; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056-NEJM200105103441904; Nevitt MC, 1998, ANN INTERN MED, V128, P793; ONeill TW, 1996, J BONE MINER RES, V11, P1010; Papaioannou A, 2001, OSTEOPOROSIS INT, V12, P870, DOI 10.1007-s001980170039; Recker RR, 1996, J BONE MINER RES, V11, P1961; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007-s001980050010; ROSS PD, 1991, ANN INTERN MED, V114, P919; Torgerson DJ, 1998, ANN RHEUM DIS, V57, P378, DOI 10.1136-ard.57.6.378; Van Der Klift M, 2002, J BONE MINER RES, V17, P1051, DOI 10.1359-jbmr.2002.17.6.1051; Van Staa TP, 2001, BONE, V29, P517, DOI 10.1016-S8756-3282(01)00614-7; Wallach S, 2000, CALCIFIED TISSUE INT, V67, P277, DOI 10.1007-s002230001146; Watts NB, 2003, J CLIN ENDOCR METAB, V88, P542, DOI 10.1210-jc.2002-020400